ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial ...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations ...

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg (USRLD: Florinef Tablets, 0.1 mg).

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.

New Delhi: Arijit Sengupta has been appointed as the new Chief Marketing Officer at Zydus Wellness. Before joining Zydus, ...

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Macquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, ...

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] The Division Bench of the D ...

Arijit Sengupta joins Zydus Wellness as chief marketing officer. Prior to this role, he served as the global marketing head ...